scispace - formally typeset
A

Agnese Po

Researcher at Sapienza University of Rome

Publications -  67
Citations -  2516

Agnese Po is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: microRNA & Medulloblastoma. The author has an hindex of 21, co-authored 52 publications receiving 2135 citations.

Papers
More filters
Journal ArticleDOI

Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells

TL;DR: Whereas miRNA expression is downregulated in cerebellar neuronal progenitors, it increases alongside differentiation, thereby allowing cell maturation and growth inhibition, and it is suggested that misregulation of specific miRNAs, leading to its aberrant activation, sustain cancer development.
Journal ArticleDOI

MicroRNA profiling in human medulloblastoma

TL;DR: Specific microRNA expression patterns which distinguish medulloblastoma differing in histotypes, in molecular features and in disease‐risk stratification are identified, and misregulated microRNAs expression profiles characterize human medullOBlastomas, and may provide potential targets for novel therapeutic strategies.
Journal ArticleDOI

Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination.

TL;DR: This work identifies Numb as a Hedgehog-pathway inhibitor that is downregulated in early GCPs and GCP-derived cancer cells and demonstrates that the Hedgehog transcription factor Gli1 is targeted by Numb for Itch-dependent ubiquitination, which suppresses Hedgehog signals, thus arresting growth and promoting cell differentiation.
Journal ArticleDOI

Hedgehog controls neural stem cells through p53-independent regulation of Nanog

TL;DR: It is shown that Nanog is highly expressed in SCs from postnatal cerebellum and medulloblastoma, and acts as a critical mediator of Hh‐driven self‐renewal, which represents a crucial component of an integrated circuitry determining cell fate decision and involved in the maintenance of cancer SCs.